Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126035541 | 12603554 | 1 | I | 20160720 | 20160728 | 20160728 | EXP | TW-MYLANLABS-2016M1030599 | MYLAN | CHONG C-H, LAI G-M, LIN J-T. CENTRAL PONTINE MYELINOLYSIS (CPM) AND EXTRAPONTINE MYELINOLYSIS (EPM) FOLLOWING CONCURRENT CHEMORADIOTHERAPY FOR NASOPHARYNGEAL CARCINOMA. J-CANCER-RES-PRACT 2016;3(2):58-62. | 0.00 | Y | 0.00000 | 20160728 | OT | TW | TW |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126035541 | 12603554 | 1 | SS | DOCETAXEL. | DOCETAXEL | 1 | Unknown | 60 MG/M2 SINGLE 1 H INFUSION ON DAY 1 OF THE COURSE | U | U | 0 | ||||||||
| 126035541 | 12603554 | 2 | PS | CISPLATIN. | CISPLATIN | 1 | Unknown | 80 MG/M2 SINGLE 6 H INFUSION ON DAY 1 OF THE COURSE | U | U | 91062 | ||||||||
| 126035541 | 12603554 | 3 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | Unknown | 800 MG/M2 AS CONTINUOUS PUMP FROM DAY 1 TO 4 OF THE COURSE | U | U | 0 | ||||||||
| 126035541 | 12603554 | 4 | SS | SODIUM CHLORIDE. | SODIUM CHLORIDE | 1 | Unknown | 3% SODIUM CHLORIDE PUMP AT THE RATE OF 20 ML/H | 0 | ||||||||||
| 126035541 | 12603554 | 5 | C | PIPERACILLIN AND TAZOBACTAM | PIPERACILLIN SODIUMTAZOBACTAM SODIUM | 1 | Unknown | 3375 MG EVERY 6 H | 0 | ||||||||||
| 126035541 | 12603554 | 6 | C | POTASSIUM CHLORIDE. | POTASSIUM CHLORIDE | 1 | Unknown | 60 MEQ | 0 | ||||||||||
| 126035541 | 12603554 | 7 | C | AMPHOTERICIN B. | AMPHOTERICIN B | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126035541 | 12603554 | 1 | Nasopharyngeal cancer recurrent |
| 126035541 | 12603554 | 2 | Nasopharyngeal cancer recurrent |
| 126035541 | 12603554 | 3 | Nasopharyngeal cancer recurrent |
| 126035541 | 12603554 | 4 | Hyponatraemia |
| 126035541 | 12603554 | 5 | Febrile neutropenia |
| 126035541 | 12603554 | 7 | Febrile neutropenia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126035541 | 12603554 | OT |
| 126035541 | 12603554 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126035541 | 12603554 | Hyponatraemia | |
| 126035541 | 12603554 | Inappropriate antidiuretic hormone secretion | |
| 126035541 | 12603554 | Osmotic demyelination syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |